Naldemedine
Peripheral Opioid Receptor Antagonists
Sold as Rizmoic
- Drug class
- Peripheral Opioid Receptor Antagonists
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Naldemedine is an active pharmaceutical ingredient in the Peripheral Opioid Receptor Antagonists group (A06AH). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| EU European Union | EMA | 1 | December 10, 2025 |
EUEuropean Union· EMA
1 product
Uses
Rizmoic is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have previously been treated with a laxative.
How to take
Drug interactions
Known interactions involving Naldemedine. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]European Medicines Agency · EMEA/H/C/004256 · revised December 10, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.